These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6161427)

  • 41. [Protection of the myocardium during heart transplantation].
    Kazakov EN; Kobakhidze EA; Obukhov VA; Ryklin VA; Minchenko BI
    Vestn Akad Med Nauk SSSR; 1981; (10):31-7. PubMed ID: 7032113
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of hypothermic, cardioplegic protection of the global ischemic canine myocardium.
    Hess ML; Krause SM; Greenfield LJ
    J Thorac Cardiovasc Surg; 1980 Aug; 80(2):293-301. PubMed ID: 6447234
    [No Abstract]   [Full Text] [Related]  

  • 43. Advances in myocardial protection?
    Khuri SF
    J Med Liban; 1995; 43(3):126-30. PubMed ID: 8885542
    [No Abstract]   [Full Text] [Related]  

  • 44. Retrograde coronary sinus perfusion of cold cardioplegic solutions in the presence of coronary arterial occlusions. Experimental study.
    Saylam A; Aytaç A; Andaç O; Tuncer I; Aslan A
    Thorac Cardiovasc Surg; 1982 Dec; 30(6):378-82. PubMed ID: 6187096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of three methods of myocardial protection.
    Isselhard W; Schorn B; Hügel W; Uekermann U
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):329-36. PubMed ID: 6161431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of various forms of myocardial protection on cardiac function, metabolism, and blood flow (author's transl)].
    Klooker P; Hilse B; Mittmann U; Saggau W; Tanzeem A; Weckler GJ
    Chir Forum Exp Klin Forsch; 1980; ():285-90. PubMed ID: 7389467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Subendocardial ischemia and protection of the myocardium].
    Ann Chir Thorac Cardiovasc; 1977 Oct; 16(4):307-14. PubMed ID: 345939
    [No Abstract]   [Full Text] [Related]  

  • 48. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
    Catinella FP; Cunningham JN; Spencer FC
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothermic cardioplegia to protect the myocardium in heart surgery.
    Deyan S
    Chin Med J (Engl); 1979 Aug; 92(8):555-7. PubMed ID: 113186
    [No Abstract]   [Full Text] [Related]  

  • 50. Optimal myocardial preservation: cooling, cardioplegia, and conditioning.
    Cleveland JC; Meldrum DR; Rowland RT; Banerjee A; Harken AH
    Ann Thorac Surg; 1996 Feb; 61(2):760-8. PubMed ID: 8572815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of the ischemic myocardium calcium-free cardioplegic infusates and the additive effects of coronary infusion and ischemia in the induction of the calcium paradox.
    Jynge P
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):303-9. PubMed ID: 6161428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reduction of myocardial reperfusion damage using hypocalcemic, hyperkalemic, alkaline blood during post-ischemic oxygen resaturation].
    Fey KH; Follette DM; Mulder DG; Maloney JV; Buckeberg GD
    Chir Forum Exp Klin Forsch; 1979; ():39-42. PubMed ID: 37051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Theoretical basis and clinical application of a continuous control of different methods of induced cardiac arrest by means of myocardial pH-measurement (author's transl)].
    Knoll D; Bretschneider HJ; Gröne HJ; Hellberg K; Kirchhoff PG; Kohl FV; Koncz J; Nordbeck H; Stapenhorst K; Spieckermann PG
    Thoraxchir Vask Chir; 1974 Dec; 22(6):575-81. PubMed ID: 4548966
    [No Abstract]   [Full Text] [Related]  

  • 55. [Crystalloid and hematic cardioplegia as methods of myocardial protection].
    Rodríguez Mejías R; Pérez Rodríguez M; de las Mulas Béjar M
    Rev Esp Anestesiol Reanim; 1986; 33(1):4-10. PubMed ID: 2939508
    [No Abstract]   [Full Text] [Related]  

  • 56. [Reanimation of warm-blooded heart after ischemia from the functional and metabolic viewpoint. Annual experiments].
    Merguet H
    Ergeb Chir Orthop; 1971; 55():72-122. PubMed ID: 5098304
    [No Abstract]   [Full Text] [Related]  

  • 57. Reperfusion of inflow-limited myocardium following hypothermic potassium-induced cardioplegia.
    Chitwood WR; Hill RC; Wechsler AS
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):49-56. PubMed ID: 6738102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.
    Bernard M; Menasche P; Canioni P; Fontanarava E; Grousset C; Piwnica A; Cozzone P
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. Experimental and clinical study.
    Follette DM; Mulder DG; Maloney JV; Buckberg GD
    J Thorac Cardiovasc Surg; 1978 Nov; 76(5):604-19. PubMed ID: 703365
    [No Abstract]   [Full Text] [Related]  

  • 60. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.
    Liu X; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
    Circulation; 1994 Nov; 90(5 Pt 2):II316-20. PubMed ID: 7955273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.